Your Money with Michelle Martin (9am - 12pm)Your Money with Michelle Martin (9am - 12pm)

Money and Me: How is Guardant Health improving clinical outcomes for cancer patients?

View descriptionShare

Simranjit Singh is the CEO of Guardant Health, a precision oncology company that launched the first FDA-approved blood test for genomic testing across all solid cancers about 2 years ago. And just recently, Guardant Health AMEA was involved in a partnership with Adicon Holdings Limited, a leading independent clinical laboratory company based in China, to boost global research and diagnostic oncology efforts. Simranjit Singh joins Michelle Martin on Money and Me as he gives a breakdown of Guardant’s portfolio and efforts to effectively revolutionise the continuum of cancer care and improve clinical outcomes for cancer patients.

  • Facebook
  • X (Twitter)
  • WhatsApp
  • Email
  • Download

In 2 playlist(s)

  1. Your Money with Michelle Martin

    3,142 clip(s)

  2. Money and Me

    952 clip(s)

Your Money with Michelle Martin (9am - 12pm)

It’s all about Your Money with Michelle Martin from 9am to 12pm. How to save, invest and make the be 
Social links
Follow podcast
Recent clips
Browse 1,798 clip(s)